General Information of the Compound
Compound ID |
CP0016407
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(Z)-Hymenialdisine
Show/Hide
|
||||||||||||||||||
Synonyms |
(4Z)-4-(2-amino-4-oxo-1H-imidazol-5-ylidene)-2-bromo-1,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one
(Z)-Hymenialdisine
10Z-Hymenialdisine
4-(2-Amino-4-oxo-2-imidazolidin-5-ylidene)-2-bromo-4,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one
4-(2-Amino-5-oxo-3,5-dihydro-imidazol-4-ylidene)-2-bromo-4,5,6,7-tetrahydro-1H-pyrrolo[2,3-c]azepin-8-one
82005-12-7
95569-43-0
AC1MHZEP
BDBM7491
CHEMBL361708
Hymenialdisine
Hymenialdisine, 1
MolPort-006-394-608
NSC607173
SCHEMBL15426167
SCHEMBL155899
STO156
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C11H10BrN5O2
|
||||||||||||||||||
Molecular Weight |
324.138
|
||||||||||||||||||
Canonical SMILES |
NC1=NC(=O)\C(N1)=C1/CCNC(=O)c2[nH]c(Br)cc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C11H10BrN5O2/c12-6-3-5-4(7-10(19)17-11(13)16-7)1-2-14-9(18)8(5)15-6/h3,15H,1-2H2,(H,14,18)(H3,13,16,17,19)/b7-4-
Show/Hide
|
||||||||||||||||||
InChIKey |
ATBAETXFFCOZOY-DAXSKMNVSA-N
|
||||||||||||||||||
CAS |
95569-43-0
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound